Innovating Works

ULS COIMBRA

TrustED: Enabling Trustworthy European Data Spaces through Self Sovereign Identity and Privacy Preserving Tec... Data-driven innovation will bring enormous benefits for citizens, affecting all sectors of activity and the daily lives of all Europeans. It...
2024-07-09 - 2027-09-30 | Financiado
COVend: Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stag... UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 More than 2.7 million hospitalisations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in...
2021-11-12 - 2025-01-31 | Financiado
SAFE-Infusion: Stop Adverse Fluid Events in Infusion weak link tube connection and air removal devices for safer... UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-EIC-FTI-2018-2020 Intravenous (IV) therapy is the most performed invasive treatment with 3.8 bn disposables tubes used annually. This procedure is not safe, n...
2021-03-08 - 2024-09-30 | Financiado
ROSIA: Remote Rehabilitation Service for Isolated Areas UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-SC1-DTH-2018-2020 Some pathologies like stroke, heart attack, COVID-19 or hip-replacement, may have a dramatic impact in the people health and well-being. Reh...
2020-12-11 - 2025-06-30 | Financiado
ENVISION: Intelligent plug and play digital tool for real time surveillance of COVID 19 patients and smart dec... UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of in...
2020-10-13 - 2023-07-31 | Financiado
VEMoS: Virtual eye model system for personalised refractive surgery treatment UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-EIC-FTI-2018-2020 The incidence of myopia is predicted to rise from 28% of the global population in 2010 to almost 50% in 2050. Factors such as population agi...
2019-11-05 - 2023-09-30 | Financiado
Syn2Psy: Synaptic Dysfunction in Neuropsychiatric Disorders UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-MSCA-ITN-2018 The large public health burden and individual suffering associated with mental disorders speaks to the need to study their biological underp...
2018-08-20 - 2023-08-31 | Financiado
NANOSTEM: New nanomaterials for neural stem cells drug delivery UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-MSCA-ITN-2017 Brain conditions such as neurodegenerative diseases, stroke and traumatic injuries are a mayor burden in modern society. Because neural stem...
2017-08-30 - 2022-05-31 | Financiado
ZIKAction: ZIKAction Preparedness research and action network on maternal paediatric axis of ZIKV infection i... UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-SC1-2016-2017 ZIKAction proposes to set up a multidisciplinary research network across Latin America with a focus on maternal and child health to coordina...
2016-11-16 - 2021-09-30 | Financiado
MASSTRPLAN: MASS Spectrometry TRaining network for Protein Lipid adduct ANalysis UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-MSCA-ITN-2015 MASSTRPLAN will train the next generation of interdisciplinary research leaders in advanced molecular analytical techniques to detect oxidiz...
2015-08-07 - 2019-09-30 | Financiado
GLORIA: Comparing the effectiveness and safety of additional low dose glucocorticoid in treatment strategies... UNIDADE LOCAL DE SAUDE DE COIMBRA EPE participó en un H2020: H2020-PHC-2014-2015 GLORIA aims to prove that the addition of chronic low dose glucocorticoids (GC) to current antirheumatic therapy is highly cost-effective an...
2015-04-08 - 2021-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.